CDKN2A and neoplasm: However, the options recommended in most cases did not vary except where as an alternative to definitive RT alone or surgery alone, treatment with RT plus systemic therapy was recommended for T1 N1 p16-negative but not for p16-positive tumours with a single node ≤ 3 cm.